O	0	16	Selenoperoxidase	Selenoperoxidase	NN	B-NP
O	16	17	-	-	HYPH	I-NP
O	17	26	dependent	dependent	JJ	I-NP
O	27	38	glutathione	glutathione	NN	I-NP
O	39	44	cycle	cycle	NN	I-NP
O	45	53	activity	activity	NN	I-NP
O	54	56	in	in	IN	B-PP
O	57	65	peroxide	peroxide	NN	B-NP
O	65	66	-	-	HYPH	B-NP
O	66	76	challenged	challenge	VBN	I-NP
B-Cell	77	85	leukemia	leukemia	NN	I-NP
I-Cell	86	91	cells	cell	NNS	I-NP
O	91	92	.	.	.	O

O	94	100	Murine	Murine	JJ	B-NP
B-Cell	101	109	leukemia	leukemia	NN	I-NP
I-Cell	110	115	L1210	L1210	NN	I-NP
I-Cell	116	121	cells	cell	NNS	I-NP
O	122	130	rendered	render	VBD	B-VP
O	131	140	deficient	deficient	JJ	B-ADJP
O	141	143	in	in	IN	B-PP
O	144	155	glutathione	glutathione	NN	B-NP
O	156	166	peroxidase	peroxidase	NN	I-NP
O	167	168	(	(	(	O
O	168	171	GPX	GPX	NN	B-NP
O	171	172	)	)	)	O
O	173	176	and	and	CC	O
O	177	189	phospholipid	phospholipid	NN	B-NP
O	190	203	hydroperoxide	hydroperoxide	NN	I-NP
O	204	215	glutathione	glutathione	NN	I-NP
O	216	226	peroxidase	peroxidase	NN	I-NP
O	227	228	(	(	(	O
O	228	233	PHGPX	PHGPX	NN	B-NP
O	233	234	)	)	)	O
O	235	237	by	by	IN	B-PP
O	238	240	Se	Se	NN	B-NP
O	241	252	deprivation	deprivation	NN	I-NP
O	253	254	(	(	(	O
B-Cell	254	255	L	L	NN	B-NP
I-Cell	255	256	.	.	.	O
I-Cell	256	258	Se	Se	NN	B-NP
I-Cell	258	259	(	(	(	O
I-Cell	259	260	-	-	SYM	O
I-Cell	260	261	)	)	)	O
I-Cell	262	267	cells	cell	NNS	B-NP
O	267	268	)	)	)	O
O	269	273	were	be	VBD	B-VP
O	274	279	found	find	VBN	I-VP
O	280	282	to	to	TO	I-VP
O	283	285	be	be	VB	I-VP
O	286	290	more	more	RBR	B-ADJP
O	291	300	sensitive	sensitive	JJ	I-ADJP
O	301	303	to	to	TO	B-VP
O	304	308	tert	tert	VB	I-VP
O	308	309	-	-	HYPH	B-NP
O	309	314	butyl	butyl	NN	I-NP
O	315	328	hydroperoxide	hydroperoxide	NN	I-NP
O	329	330	(	(	(	O
O	330	331	t	t	NN	B-NP
O	331	332	-	-	HYPH	B-NP
O	332	337	BuOOH	BuOOH	NN	I-NP
O	337	338	)	)	)	O
O	339	351	cytotoxicity	cytotoxicity	NN	B-NP
O	352	356	than	than	IN	B-PP
O	357	359	Se	Se	NN	B-NP
O	359	360	-	-	HYPH	B-NP
O	360	367	replete	replete	JJ	I-NP
O	368	376	controls	control	NNS	I-NP
O	377	378	(	(	(	O
B-Cell	378	379	L	L	NN	B-NP
I-Cell	379	380	.	.	.	O
I-Cell	380	382	Se	Se	NN	B-NP
I-Cell	382	383	(	(	(	O
I-Cell	383	384	+	+	SYM	O
I-Cell	384	385	)	)	)	O
I-Cell	386	391	cells	cell	NNS	B-NP
O	391	392	)	)	)	O
O	392	393	.	.	.	O

O	394	399	Human	Human	JJ	B-NP
B-Cell	400	404	K562	K562	NN	I-NP
I-Cell	405	410	cells	cell	NNS	I-NP
O	410	411	,	,	,	O
O	412	417	which	which	WDT	B-NP
O	418	425	express	express	VBP	B-VP
O	426	431	PHGPX	PHGPX	NN	B-NP
O	431	432	,	,	,	O
O	433	436	but	but	CC	O
O	437	440	not	not	RB	O
O	441	444	GPX	GPX	NN	B-NP
O	444	445	,	,	,	O
O	446	450	were	be	VBD	B-VP
O	451	455	also	also	RB	B-ADVP
O	456	460	more	more	RBR	B-ADJP
O	461	470	sensitive	sensitive	JJ	I-ADJP
O	471	473	to	to	TO	B-PP
O	474	475	t	t	NN	B-NP
O	475	476	-	-	HYPH	B-NP
O	476	481	BuOOH	BuOOH	NN	I-NP
O	482	484	in	in	IN	B-PP
O	485	488	the	the	DT	B-NP
O	489	491	Se	Se	NN	I-NP
O	491	492	-	-	HYPH	B-NP
O	492	501	deficient	deficient	JJ	I-NP
O	502	503	(	(	(	O
B-Cell	503	504	K	K	NN	B-NP
I-Cell	504	505	.	.	.	O
I-Cell	505	507	Se	Se	NN	B-NP
I-Cell	507	508	(	(	(	O
I-Cell	508	509	-	-	SYM	B-NP
I-Cell	509	510	)	)	)	O
O	510	511	)	)	)	O
O	512	516	than	than	IN	B-PP
O	517	519	Se	Se	NN	B-NP
O	519	520	-	-	HYPH	O
O	520	529	satisfied	satisfy	VBN	B-ADJP
O	530	531	(	(	(	O
B-Cell	531	532	K	K	NN	B-NP
I-Cell	532	533	.	.	.	O
I-Cell	533	535	Se	Se	NN	B-NP
I-Cell	535	536	(	(	(	O
I-Cell	536	537	+	+	SYM	B-NP
I-Cell	537	538	)	)	)	O
O	538	539	)	)	)	O
O	540	549	condition	condition	NN	B-NP
O	549	550	.	.	.	O

O	551	553	In	In	IN	B-PP
O	554	563	examining	examine	VBG	B-VP
O	564	567	the	the	DT	B-NP
O	568	577	metabolic	metabolic	JJ	I-NP
O	578	583	basis	basis	NN	I-NP
O	584	587	for	for	IN	B-PP
O	588	604	selenoperoxidase	selenoperoxidase	NN	B-NP
O	604	605	-	-	HYPH	B-NP
O	605	614	dependent	dependent	JJ	I-NP
O	615	625	resistance	resistance	NN	I-NP
O	625	626	,	,	,	O
O	627	629	we	we	PRP	B-NP
O	630	635	found	find	VBD	B-VP
O	636	640	that	that	IN	B-SBAR
O	641	648	glucose	glucose	NN	B-NP
O	648	649	-	-	HYPH	B-NP
O	649	656	replete	replete	JJ	I-NP
B-Cell	657	659	Se	Se	NN	I-NP
I-Cell	659	660	(	(	(	O
I-Cell	660	661	-	-	SYM	O
I-Cell	661	662	)	)	)	O
I-Cell	663	668	cells	cell	NNS	B-NP
O	669	675	reduce	reduce	VBP	B-VP
O	676	677	t	t	NN	B-NP
O	677	678	-	-	HYPH	B-NP
O	678	683	BuOOH	BuOOH	NN	I-NP
O	684	686	to	to	TO	B-PP
O	687	688	t	t	NN	B-NP
O	688	689	-	-	HYPH	B-NP
O	689	696	butanol	butanol	NN	I-NP
O	697	700	far	far	RB	B-ADVP
O	701	705	more	more	RBR	I-ADVP
O	706	712	slowly	slowly	RB	I-ADVP
O	713	717	than	than	IN	B-PP
B-Cell	718	720	Se	Se	NN	B-NP
I-Cell	720	721	(	(	(	O
I-Cell	721	722	+	+	SYM	O
I-Cell	722	723	)	)	)	O
I-Cell	724	729	cells	cell	NNS	B-NP
O	729	730	,	,	,	O
O	731	734	the	the	DT	B-NP
O	735	740	ratio	ratio	NN	I-NP
O	741	743	of	of	IN	B-PP
O	744	747	the	the	DT	B-NP
O	748	753	first	first	JJ	I-NP
O	753	754	-	-	HYPH	I-NP
O	754	759	order	order	NN	I-NP
O	760	764	rate	rate	NN	I-NP
O	765	774	constants	constant	NNS	I-NP
O	775	788	approximating	approximate	VBG	B-VP
O	789	793	that	that	DT	B-NP
O	794	796	of	of	IN	B-PP
O	797	800	the	the	DT	B-NP
O	801	804	GPX	GPX	NN	I-NP
O	805	815	activities	activity	NNS	I-NP
O	816	817	(	(	(	O
B-Cell	817	822	L1210	L1210	NN	B-NP
I-Cell	823	828	cells	cell	NNS	I-NP
O	828	829	)	)	)	O
O	830	832	or	or	CC	O
O	833	838	PHGPX	PHGPX	NN	B-NP
O	839	849	activities	activity	NNS	I-NP
O	850	851	(	(	(	O
B-Cell	851	855	K562	K562	NN	B-NP
I-Cell	856	861	cells	cell	NNS	I-NP
O	861	862	)	)	)	O
O	862	863	.	.	.	O

O	864	874	Monitoring	Monitor	VBG	B-VP
O	875	883	peroxide	peroxide	NN	B-NP
O	883	884	-	-	HYPH	B-NP
O	884	891	induced	induce	VBN	I-NP
O	892	899	changes	change	NNS	I-NP
O	900	902	in	in	IN	B-PP
O	903	906	GSH	GSH	NN	B-NP
O	907	910	and	and	CC	I-NP
O	911	915	GSSG	GSSG	NN	I-NP
O	916	920	gave	give	VBD	B-VP
O	921	931	consistent	consistent	JJ	B-NP
O	932	939	results	result	NNS	I-NP
O	939	940	;	;	:	O
O	941	942	e	e	NN	B-NP
O	942	943	.	.	.	O
O	943	944	g	g	NN	B-NP
O	944	945	.	.	NN	I-NP
O	945	946	,	,	,	O
O	947	954	glucose	glucose	NN	B-NP
O	954	955	-	-	HYPH	B-VP
O	955	963	depleted	deplete	VBN	B-NP
B-Cell	964	965	L	L	NN	I-NP
I-Cell	965	966	.	.	.	O
I-Cell	966	968	Se	Se	NN	B-NP
I-Cell	968	969	(	(	(	O
I-Cell	969	970	+	+	SYM	O
I-Cell	970	971	)	)	)	O
I-Cell	972	977	cells	cell	NNS	B-NP
O	978	987	exhibited	exhibit	VBD	B-VP
O	988	989	a	a	DT	B-NP
O	990	995	first	first	JJ	I-NP
O	996	1001	order	order	NN	I-NP
O	1002	1006	loss	loss	NN	I-NP
O	1007	1009	of	of	IN	B-PP
O	1010	1013	GSH	GSH	NN	B-NP
O	1014	1018	that	that	WDT	B-NP
O	1019	1022	was	be	VBD	B-VP
O	1023	1036	substantially	substantially	RB	B-ADJP
O	1037	1043	faster	faster	RBR	I-ADJP
O	1044	1048	than	than	IN	B-PP
O	1049	1053	that	that	DT	B-NP
O	1054	1056	of	of	IN	B-PP
O	1057	1064	glucose	glucose	NN	B-NP
O	1064	1065	-	-	HYPH	O
O	1065	1073	depleted	deplete	VBN	B-NP
B-Cell	1074	1075	L	L	NN	I-NP
I-Cell	1075	1076	.	.	.	O
I-Cell	1076	1078	Se	Se	NN	B-NP
I-Cell	1078	1079	(	(	(	O
I-Cell	1079	1080	-	-	SYM	O
I-Cell	1080	1081	)	)	)	O
I-Cell	1082	1087	cells	cell	NNS	B-NP
O	1087	1088	.	.	.	O

O	1089	1094	Under	Under	IN	B-PP
O	1095	1098	the	the	DT	B-NP
O	1099	1109	conditions	condition	NNS	I-NP
O	1110	1114	used	use	VBN	B-VP
O	1114	1115	,	,	,	O
O	1116	1124	peroxide	peroxide	NN	B-NP
O	1124	1125	-	-	HYPH	B-VP
O	1125	1132	induced	induce	VBN	B-NP
O	1133	1143	conversion	conversion	NN	I-NP
O	1144	1146	of	of	IN	B-PP
O	1147	1150	GSH	GSH	NN	B-NP
O	1151	1153	to	to	TO	B-PP
O	1154	1158	GSSG	GSSG	NN	B-NP
O	1159	1164	could	could	MD	B-VP
O	1165	1167	be	be	VB	I-VP
O	1168	1186	stoichiometrically	stoichiometrically	RB	I-VP
O	1187	1195	reversed	reverse	VBN	I-VP
O	1196	1198	by	by	IN	B-PP
O	1199	1210	resupplying	resupplye	VBG	B-VP
O	1211	1212	D	D	NN	B-NP
O	1212	1213	-	-	HYPH	B-NP
O	1213	1220	glucose	glucose	NN	I-NP
O	1220	1221	,	,	,	O
O	1222	1232	indicating	indicate	VBG	B-VP
O	1233	1237	that	that	IN	B-SBAR
O	1238	1240	no	no	DT	B-NP
O	1241	1252	significant	significant	JJ	I-NP
O	1253	1258	lysis	lysis	NN	I-NP
O	1259	1261	or	or	CC	I-NP
O	1262	1266	GSSG	GSSG	NN	I-NP
O	1267	1273	efflux	efflux	NN	I-NP
O	1274	1277	and	and	CC	O
O	1277	1278	/	/	SYM	B-NP
O	1278	1280	or	or	CC	O
O	1281	1292	interchange	interchange	NN	B-NP
O	1293	1296	had	have	VBD	B-VP
O	1297	1302	taken	take	VBN	I-VP
O	1303	1308	place	place	NN	B-NP
O	1308	1309	.	.	.	O

O	1310	1313	The	The	DT	B-NP
O	1314	1322	apparent	apparent	JJ	I-NP
O	1323	1328	first	first	JJ	I-NP
O	1328	1329	-	-	HYPH	I-NP
O	1329	1334	order	order	NN	I-NP
O	1335	1339	rate	rate	NN	I-NP
O	1340	1348	constant	constant	NN	I-NP
O	1349	1352	for	for	IN	B-PP
O	1353	1356	GSH	GSH	NN	B-NP
O	1357	1362	decay	decay	NN	I-NP
O	1363	1372	increased	increase	VBD	B-VP
O	1373	1386	progressively	progressively	RB	B-ADVP
O	1387	1390	for	for	IN	B-PP
B-Cell	1391	1396	L1210	L1210	NN	B-NP
I-Cell	1397	1402	cells	cell	NNS	I-NP
O	1403	1413	expressing	express	VBG	B-VP
O	1414	1415	a	a	DT	B-NP
O	1416	1421	range	range	NN	I-NP
O	1422	1424	of	of	IN	B-PP
O	1425	1428	GPX	GPX	NN	B-NP
O	1429	1439	activities	activity	NNS	I-NP
O	1440	1444	from	from	IN	B-PP
O	1445	1458	approximately	approximately	RB	B-NP
O	1459	1460	5	5	CD	I-NP
O	1460	1461	%	%	NN	I-NP
O	1462	1464	to	to	TO	I-NP
O	1465	1468	100	100	CD	I-NP
O	1468	1469	%	%	NN	I-NP
O	1469	1470	,	,	,	O
O	1471	1484	demonstrating	demonstrate	VBG	B-VP
O	1485	1489	that	that	IN	B-SBAR
O	1490	1498	peroxide	peroxide	NN	B-NP
O	1499	1513	detoxification	detoxification	NN	I-NP
O	1514	1516	is	be	VBZ	B-VP
O	1517	1525	strictly	strictly	RB	B-ADJP
O	1526	1535	dependent	dependent	JJ	I-ADJP
O	1536	1538	on	on	IN	B-PP
O	1539	1545	enzyme	enzyme	NN	B-NP
O	1546	1553	content	content	NN	I-NP
O	1553	1554	.	.	.	O

O	1555	1558	The	The	DT	B-NP
O	1559	1566	initial	initial	JJ	I-NP
O	1567	1571	rate	rate	NN	I-NP
O	1572	1574	of	of	IN	B-PP
O	1575	1580	14CO2	14CO2	NN	B-NP
O	1581	1588	release	release	NN	I-NP
O	1589	1593	from	from	IN	B-PP
O	1594	1595	D	D	NN	B-NP
O	1595	1596	-	-	HYPH	B-NP
O	1596	1597	[	[	(	B-NP
O	1597	1598	1	1	CD	I-NP
O	1598	1599	-	-	HYPH	I-NP
O	1599	1602	14C	14C	NN	I-NP
O	1602	1603	]	]	)	I-NP
O	1603	1610	glucose	glucose	NN	I-NP
O	1611	1619	supplied	supply	VBN	B-VP
O	1620	1622	in	in	IN	B-PP
O	1623	1626	the	the	DT	B-NP
O	1627	1633	medium	medium	NN	I-NP
O	1634	1637	was	be	VBD	B-VP
O	1638	1642	much	much	RB	B-ADJP
O	1643	1650	greater	great	JJR	I-ADJP
O	1651	1654	for	for	IN	B-PP
B-Cell	1655	1656	L	L	NN	B-NP
I-Cell	1656	1657	.	.	.	O
I-Cell	1657	1659	Se	Se	NN	B-NP
I-Cell	1659	1660	(	(	(	O
I-Cell	1660	1661	+	+	SYM	B-NP
I-Cell	1661	1662	)	)	)	O
O	1663	1665	or	or	CC	O
B-Cell	1666	1667	K	K	NN	B-NP
I-Cell	1667	1668	.	.	.	O
I-Cell	1668	1670	Se	Se	NN	B-NP
I-Cell	1670	1671	(	(	(	O
I-Cell	1671	1672	+	+	SYM	O
I-Cell	1672	1673	)	)	)	O
I-Cell	1674	1679	cells	cell	NNS	B-NP
O	1680	1684	than	than	IN	B-PP
O	1685	1688	for	for	IN	B-PP
O	1689	1694	their	their	PRP$	B-NP
O	1695	1705	respective	respective	JJ	I-NP
B-Cell	1706	1708	Se	Se	NN	I-NP
I-Cell	1708	1709	(	(	(	O
I-Cell	1709	1710	-	-	SYM	O
I-Cell	1710	1711	)	)	)	O
O	1712	1724	counterparts	counterpart	NNS	B-NP
O	1724	1725	,	,	,	O
O	1726	1736	consistent	consistent	JJ	B-ADJP
O	1737	1741	with	with	IN	B-PP
O	1742	1749	greater	great	JJR	B-NP
O	1750	1756	hexose	hexose	NN	I-NP
O	1757	1770	monophosphate	monophosphate	NN	I-NP
O	1771	1776	shunt	shunt	NN	I-NP
O	1777	1785	activity	activity	NN	I-NP
O	1786	1788	in	in	IN	B-PP
O	1789	1792	the	the	DT	B-NP
O	1793	1799	former	former	JJ	I-NP
O	1799	1800	.	.	.	O

O	1801	1806	These	These	DT	B-NP
O	1807	1814	results	result	NNS	I-NP
O	1815	1824	highlight	highlight	VBP	B-VP
O	1825	1828	the	the	DT	B-NP
O	1829	1839	importance	importance	NN	I-NP
O	1840	1842	of	of	IN	B-PP
O	1843	1859	selenoperoxidase	selenoperoxidase	NN	B-NP
O	1860	1866	action	action	NN	I-NP
O	1867	1869	in	in	IN	B-PP
O	1870	1873	the	the	DT	B-NP
O	1874	1885	glutathione	glutathione	NN	I-NP
O	1886	1891	cycle	cycle	NN	I-NP
O	1892	1894	as	as	IN	B-PP
O	1895	1896	a	a	DT	B-NP
O	1897	1902	means	means	NN	I-NP
O	1903	1905	by	by	IN	B-PP
O	1906	1911	which	which	WDT	B-NP
B-Cell	1912	1917	tumor	tumor	NN	B-NP
I-Cell	1918	1923	cells	cell	NNS	I-NP
O	1924	1928	cope	cope	VBP	B-VP
O	1929	1933	with	with	IN	B-PP
O	1934	1947	hydroperoxide	hydroperoxide	NN	B-NP
O	1948	1954	stress	stress	NN	I-NP
O	1954	1955	.	.	.	O

